Comments
Loading...
Perpetua Medical Analyst Ratings and Price Targets | OTC:PPTMF | Benzinga
Perpetua Medical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Perpetua Medical Corp from these most-recent analyst ratings.
Analyst Ratings for Perpetua Medical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Perpetua Medical (PPTMF) stock?
There is no price target for Perpetua Medical
What is the most recent analyst rating for Perpetua Medical (PPTMF)?
There is no analyst for Perpetua Medical
When was the last upgrade for Perpetua Medical (PPTMF)?
There is no last upgrade for Perpetua Medical
When was the last downgrade for Perpetua Medical (PPTMF)?
There is no last downgrade for Perpetua Medical.
When is the next analyst rating going to be posted or updated for Perpetua Medical (PPTMF)?
There is no next analyst rating for Perpetua Medical.
Is the Analyst Rating Perpetua Medical (PPTMF) correct?
There is no next analyst rating for Perpetua Medical.
Browse analyst ratings and price targets on all stocks.
